LOGIN
Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate for Tibial Fractures
October 2022
Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate for Tibial Fractures
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
Tibial Fracture - Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate (T-PAC): A Randomized Controlled Feasibility Study
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Forty-five patients with unilateral closed tibial diaphyseal fractures were randomized to receive either platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) with standard care or standard care alone. Primary outcomes of interest were time to painless weight bearing, radiological union (2, 8, 12, 16, 20, 26, and 39 weeks), and patient-reported outcome measures (0, 12, 26, and 39 ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.